Does ATEZOLIZUMAB Cause Hepatic failure? 371 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 371 reports of Hepatic failure have been filed in association with ATEZOLIZUMAB (Tecentriq Hybreza). This represents 1.1% of all adverse event reports for ATEZOLIZUMAB.
371
Reports of Hepatic failure with ATEZOLIZUMAB
1.1%
of all ATEZOLIZUMAB reports
221
Deaths
136
Hospitalizations
How Dangerous Is Hepatic failure From ATEZOLIZUMAB?
Of the 371 reports, 221 (59.6%) resulted in death, 136 (36.7%) required hospitalization, and 21 (5.7%) were considered life-threatening.
Is Hepatic failure Listed in the Official Label?
Yes, Hepatic failure is listed as a known adverse reaction in the official FDA drug label for ATEZOLIZUMAB.
What Other Side Effects Does ATEZOLIZUMAB Cause?
Death (3,591)
Off label use (2,340)
Disease progression (1,828)
Pyrexia (1,599)
Diarrhoea (1,490)
Fatigue (1,253)
Anaemia (1,195)
Pneumonia (1,036)
Nausea (953)
Dyspnoea (938)
What Other Drugs Cause Hepatic failure?
ACETAMINOPHEN (1,392)
RIBAVIRIN (888)
CYCLOPHOSPHAMIDE (629)
METHOTREXATE (598)
BEVACIZUMAB (558)
SOFOSBUVIR (525)
RITUXIMAB (513)
VINCRISTINE (468)
DOXORUBICIN (462)
PREDNISOLONE (425)
Which ATEZOLIZUMAB Alternatives Have Lower Hepatic failure Risk?
ATEZOLIZUMAB vs ATLANTIC SALMON OIL
ATEZOLIZUMAB vs ATOGEPANT
ATEZOLIZUMAB vs ATOMOXETINE
ATEZOLIZUMAB vs ATOMOXETINE\ATOMOXETINE
ATEZOLIZUMAB vs ATORVASTATIN